Nouveau Life Pharmaceuticals, Inc. (NOUV) is a publicly traded company in the Financial Services sector, operating within the Shell Companies industry. The company is headquartered in Ft. Lauderdale, FL, United States. The current CEO is Brian Shibley.
NOUV has IPO date of 2003-02-21, listed on the Other OTC, a market capitalization of $90K.
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012. Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.
